A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies

Clinical trial NCT01317927 · COMPLETED

Trial details

NCT number: NCT01317927
Sponsor: Spectrum Pharmaceuticals, Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Hematological Malignancy

Start date: 2010-12-01
Primary completion: 2015-06-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.